Anacardic acid (6-pentadecylsalicylic acid) induces apoptosis of prostate cancer cells through inhibition of androgen receptor and activation of p53 signaling

Chinese Journal of Cancer Research

Volumn 24, Issue 4, 2012, Pages 275-283

  Tan, Jing ^a   Chen, Binghai ^a   He, Leye ^a   Tang, Yuxin ^a   Jiang, Zhiqiang ^a   Yin, Guangmin ^a   Wang, Jinrong ^a   Jiang, Xianzhen ^a  

^a Central South University   (China)

Author keywords

anacardic acid; apoptosis; LNCaP; p300; p53; Prostate cancer

Indexed keywords

ANACARDIC ACID (6 PENTADECYLSALICYLIC ACID); ANDROGEN RECEPTOR; ANTINEOPLASTIC AGENT; P21 ACTIVATED KINASE; PROTEIN P53; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRAIN LNCAP; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; GENE; HUMAN; HUMAN CELL; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 84875439174     PISSN: 10009604     EISSN: 19930631     Source Type: Journal    
DOI: 10.1007/s11670-012-0264-y     Document Type: Article

References (30)

1. Gururajan M, Posadas EM, Chung LW. Future perspectives of prostate cancer therapy. Transl Androl Urol 2012;1:19-32.
2. Britto AC, de Oliveira AC, Henriques RM, et al. In vitro and in vivo antitumor effects of the essential oil from the leaves of Guatteria friesiana. Planta Med 2012;78:409-414.
3. de Melo JG, Santos AG, de Amorim EL, et al. Medicinal plants used as antitumor agents in Brazil: an ethnobotanical approach. Evid Based Complement Alternat Med 2011;2011:365359.
4. Sowmyalakshmi S, Nur-E-Alam M, Akbarsha MA, et al. Investigation on Semecarpus Lehyam - a Siddha medicine for breast cancer. Planta 2005;220:910-918.
5. Rea AI, Schmidt JM, Setzer WN, et al. Cytotoxic activity of Ozoroa insignis from Zimbabwe. Fitoterapia 2003;74:732-735.
6. Devipriya B, Kumaradhas P. Probing the effect of intermolecular interaction and understanding the electrostatic moments of anacardic acid in the active site of p300 enzyme via DFT and charge density analysis. J Mol Graph Model 2012;34:57-66.
7. Sukumari-Ramesh S, Singh N, Jensen MA, et al. Anacardic acid induces caspase-independent apoptosis and radiosensitizes pituitary adenoma cells. J Neurosurg 2011;114:1681-1690.
8. Hemshekhar M, Sebastin Santhosh M, Kemparaju K, et al. Emerging Roles of Anacardic Acid and Its Derivatives: A Pharmacological Overview. Basic Clin Pharmacol Toxicol 2011. [Epub ahead of print].
9. Cui L, Miao J, Furuya T, et al. Histone acetyltransferase inhibitor anacardic acid causes changes in global gene expression during in vitro Plasmodium falciparum development. Eukaryot Cell 2008;7:1200-1210.
10. Ghizzoni M, Boltjes A, Graaf C, et al. Improved inhibition of the histone acetyltransferase PCAF by an anacardic acid derivative. Bioorg Med Chem 2010;18:5826-5834.
11. Sun Y, Jiang X, Chen S, et al. Inhibition of histone acetyltransferase activity by anacardic acid sensitizes tumor cells to ionizing radiation. FEBS Lett 2006;580:4353-4356.
12. Souto JA, Benedetti R, Otto K, et al. New anacardic acidinspired benzamides: histone lysine acetyltransferase activators. Chem Med Chem 2010;5:1530-1540.
13. Souto JA, Conte M, Alvarez R, et al. Synthesis of benzamides related to anacardic acid and their histone acetyltransferase (HAT) inhibitory activities. Chem Med Chem 2008;3:1435-1442.
14. Sung B, Pandey MK, Ahn KS, et al. Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-kappaBalpha kinase, leading to potentiation of apoptosis. Blood 2008;111:4880-4891.
15. Schultz DJ, Wickramasinghe NS, Ivanova MM, et al. Anacardic acid inhibits estrogen receptor alpha-DNA binding and reduces target gene transcription and breast cancer cell proliferation. Mol Cancer Ther 2010;9:594-605.
16. Lee C, Zhang Q, Zi X, et al. TGF-β mediated DNA methylation in prostate cancer. Transl Androl Urol 2012;1:78-88.
17. Ameri A, Alidoosti A, Hosseini Y, et al. Prognostic value of promoter hypermethylation of Retinoic Acid Receptor Beta (RARB) and CDKN2 (p16/MTS1) in prostate cancer. Chin J Cancer Res 2011;23:306-311.
18. Ilic D, Forbes KM, Hassed C. Lycopene for the prevention of prostate cancer. Cochrane Database Syst Rev 2011;11:CD008007.
19. Namiki M, Ueno S, Kitagawa Y. Role of hormonal therapy for prostate cancer: perspective from Japanese experiences. Transl Androl Urol 2012;1:160-172.
20. Wolff JM, Schmid HP. Extension of the therapeutic spectrum in castration-resistant prostate cancer: Osteoclast inhibition with denosumab. Transl Androl Urol 2012;1:118-119.
21. Palozza P, Colangelo M, Simone R, et al. Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines. Carcinogenesis 2010;31:1813-1821.
22. Limpens J, Schröder FH, de Ridder CM, et al. Combined lycopene and vitamin E treatment suppresses the growth of PC-346C human prostate cancer cells in nude mice. J Nutr 2006;136:1287-1293.
23. Chun JY, Tummala R, Nadiminty N, et al. Andrographolide, an herbal medicine, inhibits interleukin-6 expression and suppresses prostate cancer cell growth. Genes Cancer 2010;1:868-876.
24. Sung B, Pandey MK, Ahn KS, et al. Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-kappaBalpha kinase, leading to potentiation of apoptosis. Blood 2008;111:4880-4891.
25. Karamouzis MV, Konstantinopoulos PA, Papavassiliou AG. Roles of CREB-binding protein (CBP)/p300 in respiratory epithelium tumorigenesis. Cell Res 2007;17:324-332.
26. Demarest SJ, Martinez-Yamout M, Chung J, et al. Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators. Nature 2002;415:549-553.
27. Wang X, Pan L, Feng Y, et al. p300 plays a role in p16(INK4a) expression and cell cycle arrest. Oncogene 2008;27:1894-1904.
28. Luo J, Li M, Tang Y, et al. Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc Natl Acad Sci U S A 2004;101:2259-2264.
29. Pan X, Zhao J, Zhang WN, et al. Induction of SOX4 by DNA damage is critical for p53 stabilization and function. Proc Natl Acad Sci U S A 2009;106:3788-3793.
30. Livengood JA, Scoggin KE, Van Orden K, et al. p53 Transcriptional activity is mediated through the SRC1-interacting domain of CBP/p300. J Biol Chem 2002;277:9054-9061.